New Zealand markets closed

MRNA Jan 2023 240.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.85000.0000 (0.00%)
As of 03:59PM EST. Market open.
Full screen
Loading interactive chart…
  • Motley Fool

    Moderna Stock: Buy, Sell, or Hold in 2023?

    Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.

  • Zacks

    Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why

    Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.

  • Motley Fool

    The Worst Mistake Moderna Investors Can Make in 2023

    Moderna (NASDAQ: MRNA) investors didn't need to have too much patience in the early days of the pandemic. The company brought its coronavirus vaccine candidate from drawing board to market in about nine months. Next year, though, Moderna investors may need to rely on their patience.